Prospective Study of the Clinical Impact of Epithelial and Mesenchymal Circulating Tumor Cells in Localized Prostate Cancer

BACKGROUND: Although circulating tumor cells (CTCs) are considered as a surrogate marker in monitoring disease progression and treatment response in late stage prostate cancer (PCa), its clinical impact in localized PCa remains unclear, indicating the limitation that is simply based on cell count. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hailong, Ding, Jie, Wu, Yanyuan, Wu, Di, Qi, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304675/
https://www.ncbi.nlm.nih.gov/pubmed/32606948
http://dx.doi.org/10.2147/CMAR.S253997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304675/
https://www.ncbi.nlm.nih.gov/pubmed/32606948
http://dx.doi.org/10.2147/CMAR.S253997

Ejemplares similares